TrialCardiovascular diabetology2023

Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia : Experiences from the randomized, controlled SOCOGAMI trial.

Elena Fortin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.